These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3899772)

  • 1. Double-blind comparison of prenylamine and penbutolol in patients with angina pectoris.
    Slegers LC; Vermeulen A; Sumajow CA
    J Int Med Res; 1985; 13(4):229-35. PubMed ID: 3899772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS; Tweddel AC; Murray RG; Lawrie TD
    Arzneimittelforschung; 1980; 30(9):1595-9. PubMed ID: 7006619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of once daily penbutolol in chronic stable angina. An objective comparison with long-acting propranolol.
    Bowles MJ; Khurmi NS; Bala Subramanian V; Raftery EB
    Int J Cardiol; 1984 Feb; 5(2):131-42. PubMed ID: 6365803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
    Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
    Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
    Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
    Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of a new beta adrenergic blocking agent (penbutolol) in the treatment of ischemic cardiopathy].
    Ortuño Aznar F; Martín Jadraque L
    Med Clin (Barc); 1985 May; 84(19):766-8. PubMed ID: 2863437
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term treatment of stable angina pectoris with penbutolol].
    Martín Jadraque L; Ortuño Aznar F
    Med Clin (Barc); 1986 Apr; 86(13):540-2. PubMed ID: 3713329
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.
    Khurmi NS; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(6):539-48. PubMed ID: 3653222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of coronary disease with the beta-blocker betapressin].
    Christandl B
    Fortschr Med; 1981 Sep; 99(36):1473-6. PubMed ID: 6117510
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenylamine in angina pectoris.
    SOSA JA; McGREGOR M
    Can Med Assoc J; 1963 Aug; 89(6):248-51. PubMed ID: 13978340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenylamine in treatment of angina.
    Tucker H; Carson P; Bass N; Massey J
    Br Heart J; 1974 Oct; 36(10):1001-4. PubMed ID: 4611457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of antianginal drugs on the exertion electrocardiogram].
    Moragrega Adame JL; Peña Vincent H
    Arch Inst Cardiol Mex; 1976; 46(3):317-24. PubMed ID: 45539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutical comparison between atenolol and nifedipine in effort angina (author's transl)].
    Gruppillo P; Battaglia R; Masoni C; Maistrello I; Masoni A
    G Ital Cardiol; 1981; 11(12):2081-7. PubMed ID: 7049817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, double cross-over trial of prenylamine in angina pectoris.
    Winsor R; Bleifer K; Cole S; Goldman IR; Karpman H; Oblath R; Stone S
    Am Heart J; 1971 Jul; 82(1):43-54. PubMed ID: 4996509
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular arrhythmias during exercise testing and daily activities in patients with stable angina pectoris before and during Aldisem and penbutolol treatment.
    Catipović-Veselica K; Skrinjarić-Cincar S; Catipović B
    Acta Med Croatica; 1993; 47(3):129-33. PubMed ID: 7509665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension.
    Graml E; Verho M; Rangoonwala B; Englert R; Häringer E; Pahnke K
    Pharmatherapeutica; 1985; 4(4):236-43. PubMed ID: 3903788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prenylamine (segontin) in angina pectoris. A double-blind test].
    Bjorum N; Christensen M; Rathsach P
    Ugeskr Laeger; 1967 Jan; 129(2):47-9. PubMed ID: 4970427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.